Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum Polystyrene Sulfonate in ESRD Hemodialysis Patients With Hyperphosphatemia (Phase Ib/IIa)
CTR20200653Phase 2Completed
- Sponsor
- Penglai Nuokang Pharmaceutical
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lanthanum polystyrene sulfonate in hyperphosphatemia, sponsored by Penglai Nuokang Pharmaceutical. Started Apr 2020; status: completed.
02
Drugs
lanthanum polystyrene sulfonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on CTR20200653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200653.